Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,403 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and Safety of Subcutaneous Vedolizumab in Patients With Moderately to Severely Active Crohn's Disease: Results From the VISIBLE 2 Randomised Trial.
Vermeire S, D'Haens G, Baert F, Danese S, Kobayashi T, Loftus EV, Bhatia S, Agboton C, Rosario M, Chen C, Zhang W, Kisfalvi K, Sandborn WJ. Vermeire S, et al. Among authors: bhatia s. J Crohns Colitis. 2022 Jan 28;16(1):27-38. doi: 10.1093/ecco-jcc/jjab133. J Crohns Colitis. 2022. PMID: 34402887 Free PMC article. Clinical Trial.
Efficacy and Safety of Vedolizumab Subcutaneous Formulation in a Randomized Trial of Patients With Ulcerative Colitis.
Sandborn WJ, Baert F, Danese S, Krznarić Ž, Kobayashi T, Yao X, Chen J, Rosario M, Bhatia S, Kisfalvi K, D'Haens G, Vermeire S. Sandborn WJ, et al. Among authors: bhatia s. Gastroenterology. 2020 Feb;158(3):562-572.e12. doi: 10.1053/j.gastro.2019.08.027. Epub 2019 Aug 28. Gastroenterology. 2020. PMID: 31470005 Free article. Clinical Trial.
Pharmacokinetics, Safety and Efficacy of Intravenous Vedolizumab in Paediatric Patients with Ulcerative Colitis or Crohn's Disease: Results from the Phase 2 HUBBLE Study.
Hyams JS, Turner D, Cohen SA, Szakos E, Kowalska-Duplaga K, Ruemmele F, Croft NM, Korczowski B, Lawrence P, Bhatia S, Kadali H, Chen C, Sun W, Rosario M, Kabilan S, Treem W, Rossiter G, Lirio RA. Hyams JS, et al. Among authors: bhatia s. J Crohns Colitis. 2022 Aug 30;16(8):1243-1254. doi: 10.1093/ecco-jcc/jjac036. J Crohns Colitis. 2022. PMID: 35301512 Free PMC article. Clinical Trial.
Safety of an investigational formulation of budesonide (budesonide oral suspension) for eosinophilic oesophagitis: an integrated safety analysis of six phase 1-3 clinical trials.
Hirano I, Dellon ES, Gupta SK, Katzka DA, Collins MH, Wojtowicz AM, Terreri B, Zhang W, Boules M, Bhatia S, Desai NK. Hirano I, et al. Among authors: bhatia s. Aliment Pharmacol Ther. 2023 May;57(10):1117-1130. doi: 10.1111/apt.17430. Epub 2023 Mar 8. Aliment Pharmacol Ther. 2023. PMID: 36890134 Clinical Trial.
OPA1 Mutation Presenting as Ethambutol-Induced Optic Neuropathy.
Jain A, Nashi S, Mailankody P, Srijithesh PR, Kulkarni GB, Alladi S, Bhatia S, Arunachal G. Jain A, et al. Among authors: bhatia s. Ann Indian Acad Neurol. 2024 Jun 5. doi: 10.4103/aian.aian_1107_23. Online ahead of print. Ann Indian Acad Neurol. 2024. PMID: 38835165 No abstract available.
Cecal bascule presenting as internal hernia.
Tian J, English H, Bhatia S, Mourad Y, Louis MA, Khan N. Tian J, et al. Among authors: bhatia s. J Surg Case Rep. 2024 May 31;2024(5):rjae366. doi: 10.1093/jscr/rjae366. eCollection 2024 May. J Surg Case Rep. 2024. PMID: 38826857 Free PMC article.
3,403 results